A polyvalent DNA prime with matched polyvalent proteinGLASE boost regimen elicited the most robust and broad lgG and V1V2 binding antibody and antibody and CV4 T cell responses among 13 HIV vaccine trials

dc.article.end-page20en
dc.article.start-page1en
dc.citation.doi10.1080/22221751.2025.2485317en
dc.contributor.authorZ Moodieen
dc.contributor.authorShuying Sue Lien
dc.contributor.authorElena E Giorgien
dc.contributor.authorLaTonya D Williamsen
dc.contributor.authorFatima Laheren
dc.contributor.authorGlenda Grayen
dc.contributor.authorE et alen
dc.date.accessioned2025-07-31T08:49:46Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/45720
dc.journal.titleA polyvalent DNA prime with matched polyvalent proteinGLASE boost regimen elicited the most robust and broad lgG and V1V2 binding antibody and antibody and CV4 T cell responses among 13 HIV vaccine trialsen
dc.journal.volume14en
dc.titleA polyvalent DNA prime with matched polyvalent proteinGLASE boost regimen elicited the most robust and broad lgG and V1V2 binding antibody and antibody and CV4 T cell responses among 13 HIV vaccine trialsen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
2.13 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client